Diligence memo · auto-generated · as of July 2, 2026
Conffianz LLC
Conffianz LLC looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Conffianz LLC operates in Pharmaceuticals, based in FAIRFAX.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Conffianz LLC has raised $500K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $500K on 2015-03-09.
Most recent recorded round closed around 2015-03-09.
Valuation (modeled)modeled
Provath models Conffianz LLC at approximately $24M (range $280K–$268M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.08× the median modeled value of Pre-Seed Pharmaceuticals companies in 2013–2015 (87 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 11.3 yr ago; this sector typically re-raises about every 13 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 13% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 31% of those peers.
Closest niche peers: IPM Safety Services, Inc., Scioderm, LLC, Chondrial Therapeutics, LLC, OnCore Biopharma, Inc., VR1 Corp.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.